Machine learning-based CT radiomics method for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: a multicenter study.

CT Coronavirus disease 2019 (COVID-19) machine learning patient discharge prognosis

Journal

Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978

Informations de publication

Date de publication:
Jul 2020
Historique:
entrez: 15 8 2020
pubmed: 15 8 2020
medline: 15 8 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) has become a global challenge since the December 2019. The hospital stay is one of the prognostic indicators, and its predicting model based on CT radiomics features is important for assessing the patients' clinical outcome. The study aimed to develop and test machine learning-based CT radiomics models for predicting hospital stay in patients with COVID-19 pneumonia. This retrospective, multicenter study enrolled patients with laboratory-confirmed SARS-CoV-2 infection and their initial CT images from 5 designated hospitals in Ankang, Lishui, Lanzhou, Linxia, and Zhenjiang between January 23, 2020 and February 8, 2020. Patients were classified into short-term (≤10 days) and long-term hospital stay (>10 days). CT radiomics models based on logistic regression (LR) and random forest (RF) were developed on features from pneumonia lesions in first four centers. The predictive performance was evaluated in fifth center (test dataset) on lung lobe- and patients-level. A total of 52 patients were enrolled from designated hospitals. As of February 20, 21 patients remained in hospital or with non-findings in CT were excluded. Therefore, 31 patients with 72 lesion segments were included in analysis. The CT radiomics models based on 6 second-order features were effective in discriminating short- and long-term hospital stay in patients with COVID-19 pneumonia, with areas under the curves of 0.97 (95% CI, 0.83-1.0) and 0.92 (95% CI, 0.67-1.0) by LR and RF, respectively, in test. The LR and RF model showed a sensitivity and specificity of 1.0 and 0.89, 0.75 and 1.0 in test respectively. As of February 28, a prospective cohort of six discharged patients were all correctly recognized as long-term stay using RF and LR models. The machine learning-based CT radiomics features and models showed feasibility and accuracy for predicting hospital stay in patients with COVID-19 pneumonia.

Sections du résumé

BACKGROUND BACKGROUND
The coronavirus disease 2019 (COVID-19) has become a global challenge since the December 2019. The hospital stay is one of the prognostic indicators, and its predicting model based on CT radiomics features is important for assessing the patients' clinical outcome. The study aimed to develop and test machine learning-based CT radiomics models for predicting hospital stay in patients with COVID-19 pneumonia.
METHODS METHODS
This retrospective, multicenter study enrolled patients with laboratory-confirmed SARS-CoV-2 infection and their initial CT images from 5 designated hospitals in Ankang, Lishui, Lanzhou, Linxia, and Zhenjiang between January 23, 2020 and February 8, 2020. Patients were classified into short-term (≤10 days) and long-term hospital stay (>10 days). CT radiomics models based on logistic regression (LR) and random forest (RF) were developed on features from pneumonia lesions in first four centers. The predictive performance was evaluated in fifth center (test dataset) on lung lobe- and patients-level.
RESULTS RESULTS
A total of 52 patients were enrolled from designated hospitals. As of February 20, 21 patients remained in hospital or with non-findings in CT were excluded. Therefore, 31 patients with 72 lesion segments were included in analysis. The CT radiomics models based on 6 second-order features were effective in discriminating short- and long-term hospital stay in patients with COVID-19 pneumonia, with areas under the curves of 0.97 (95% CI, 0.83-1.0) and 0.92 (95% CI, 0.67-1.0) by LR and RF, respectively, in test. The LR and RF model showed a sensitivity and specificity of 1.0 and 0.89, 0.75 and 1.0 in test respectively. As of February 28, a prospective cohort of six discharged patients were all correctly recognized as long-term stay using RF and LR models.
CONCLUSIONS CONCLUSIONS
The machine learning-based CT radiomics features and models showed feasibility and accuracy for predicting hospital stay in patients with COVID-19 pneumonia.

Identifiants

pubmed: 32793703
doi: 10.21037/atm-20-3026
pii: atm-08-14-859
pmc: PMC7396749
doi:

Types de publication

Journal Article

Langues

eng

Pagination

859

Informations de copyright

2020 Annals of Translational Medicine. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-3026). The authors have no conflicts of interest to declare.

Références

Sci Rep. 2015 Aug 17;5:13087
pubmed: 26278466
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
JAMA. 2020 Feb 7;:
pubmed: 32031570
Radiology. 2020 Apr;295(1):18
pubmed: 32003646
Ann Transl Med. 2020 Mar;8(5):256
pubmed: 32309403
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
Nat Commun. 2019 Jul 18;10(1):3170
pubmed: 31320621
Radiology. 2020 Aug;296(2):E15-E25
pubmed: 32083985
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264

Auteurs

Hongmei Yue (H)

CHESS-COVID-19 Group, CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China.
Department of Respiratory Medicine, The First Hospital of Lanzhou University, Lanzhou, China.
Department of Pulmonary and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou, China.

Qian Yu (Q)

Department of Radiology, Jiangsu Key Laboratory of Molecular and Functional Imaging, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.

Chuan Liu (C)

Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Yifei Huang (Y)

Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Zicheng Jiang (Z)

CHESS-COVID-19 Group, Ankang Central Hospital, Ankang, China.

Chuxiao Shao (C)

CHESS-COVID-19 Group, Zhejiang University Lishui Hospital & Lishui Central Hospital, Lishui, China.

Hongguang Zhang (H)

Department of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China.

Baoyi Ma (B)

Department of Respiratory Medicine, The People's Hospital of Linxia Hui Prefecture, Linxia, China.

Yuancheng Wang (Y)

Department of Radiology, Jiangsu Key Laboratory of Molecular and Functional Imaging, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.

Guanghang Xie (G)

Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Haijun Zhang (H)

CHESS-COVID-19 Group, CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China.

Xiaoguo Li (X)

CHESS-COVID-19 Group, CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China.

Ning Kang (N)

CHESS-COVID-19 Group, CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China.

Xiangpan Meng (X)

Department of Radiology, Jiangsu Key Laboratory of Molecular and Functional Imaging, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.

Shan Huang (S)

Department of Radiology, Jiangsu Key Laboratory of Molecular and Functional Imaging, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.

Dan Xu (D)

CHESS-COVID-19 Group, CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China.

Junqiang Lei (J)

CHESS-COVID-19 Group, CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China.

Huihong Huang (H)

CHESS-COVID-19 Group, Ankang Central Hospital, Ankang, China.

Jie Yang (J)

CHESS-COVID-19 Group, Zhejiang University Lishui Hospital & Lishui Central Hospital, Lishui, China.

Jiansong Ji (J)

CHESS-COVID-19 Group, Zhejiang University Lishui Hospital & Lishui Central Hospital, Lishui, China.

Hongqiu Pan (H)

Department of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China.

Shengqiang Zou (S)

Department of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China.

Shenghong Ju (S)

Department of Radiology, Jiangsu Key Laboratory of Molecular and Functional Imaging, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.

Xiaolong Qi (X)

CHESS-COVID-19 Group, CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China.

Classifications MeSH